Improving Anxiety Related to Chronic Pain Through a Sleep Circadian Intervention Program: A Pilot Study
Sonia López-Monzoni1,2, Gloria Hernando Benito3,4, Sofía Romero-Peralta1,2,5
1Sleep Unit, Pneumology Department, Hospital Universitario de Guadalajara, 19002 Guadalajara, Spain.
Behavioral Sciences (Basel, Switzerland)
|January 24, 2025
Summary
A Sleep and Circadian Intervention Program (SCIP) effectively reduced anxiety and depression in chronic musculoskeletal pain (CMP) patients by addressing sleep disorders like insomnia and sleep apnea. This non-pharmacological approach improved overall well-being and pain-related anxiety.
Area of Science:
- Integrative medicine
- Pain management
- Sleep medicine
Background:
- Pharmacological treatments for chronic pain face limitations including dependency, side effects, and diminishing efficacy.
- There is an urgent need for innovative non-pharmacological strategies to improve patient outcomes and reduce opioid consumption.
- Sleep disturbances are common in chronic musculoskeletal pain (CMP) and may exacerbate pain and reduce quality of life.
Purpose of the Study:
- To evaluate the impact of a Sleep and Circadian Intervention Program (SCIP) on the control of chronic musculoskeletal pain (CMP).
- To assess SCIP's effect on pain intensity, physical function, depression, anxiety, and quality of life in CMP patients.
- To investigate the prevalence of sleep disorders in CMP patients and the efficacy of targeted interventions.
Main Methods:
- A randomized clinical trial (NCT03646084) involving 49 CMP patients assigned to either SCIP or a non-SCIP control group.
- The SCIP group received treatment for diagnosed sleep disorders (restless leg syndrome, insomnia, sleep apnea) based on clinical guidelines.
- Outcomes were assessed at 6 months using self-reported questionnaires (pain, function, mood, quality of life) and polysomnography for the SCIP group.
Main Results:
- The SCIP group showed a significant reduction in the abnormal risk for anxiety (73.3% to 46.7%) and depression (53.3% to 33.3%) compared to the non-SCIP group.
- SCIP significantly improved anxiety and fear related to pain, as evidenced by the Pain Anxiety Symptoms Scale.
- The intervention effectively managed sleep disorders, particularly insomnia, in the CMP population.
Conclusions:
- The Sleep and Circadian Intervention Program (SCIP) demonstrates efficacy in improving anxiety and controlling sleep disorders in chronic musculoskeletal pain patients.
- Targeting sleep disorders, especially insomnia, is a crucial component of comprehensive CMP management.
- Larger studies are warranted to further elucidate the role of sleep interventions in chronic pain control.
Related Concept Videos
01:27Insomnia
78
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
78
01:19Management of Insomnia
229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
01:13Insufficient Sleep and Sleep Deprivation
131
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
131
01:11Understanding Sleep
217
Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
217
01:14CNS Depressants: Barbiturates and Benzodiazepines
216
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
216
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
145
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
145